Mollie directs the business and strategic activities of SAFE-BioPharma Association® and serves as the primary liaison with member companies, vendor partners and others in the growing SAFE-BioPharma community. She is a member of the association’s Board of Directors.
Mollie has more than 20 years of international trade and biopharmaceutical industry experience. Prior to joining SAFE-BioPharma Association, Ms. Shields-Uehling was principal of Shields-Uehling Associates, an international public affairs consultancy. She previously served in various leadership positions with Bristol-Myers Squibb, Wyeth, the International AIDS Vaccine Initiative (IAVI), and in the White House Office of the U.S. Trade Representative and the U.S. Foreign Commercial Service.
Kevin Chisholm, Executive Assistant to CEO/Office Administrator
Kevin assists Mollie Shields-Uehling in administering the association and is responsible for all office operations. He is a skilled events planner and, among other things, responsible for technical support for the association’s communications.
Rich Furr, Head, Global Regulatory Affairs and Chief Compliance Officer
Rich is the primary staff contact with the FDA and other global regulatory authorities. He provides staff support to a variety of SAFE-BioPharma working groups and manages the SAFE-BioPharma Product Certification Program. Prior to this position he was responsible for development of the association’s business policies, governance and compliance standards and regulatory compliance activities with the Food and Drug Administration.
Before SAFE-BioPharma, Rich worked with Churchill & Harriman, Strategic Identity Group and First Consulting Group. He also was Director, Strategic Plans for Aventis Pharmaceuticals Global Regulatory Affairs Operations. He served 20 years in the US Air Force as Signals Intelligence/Intelligence Staff Officer, Executive Officer and Squadron Commander. This included five years on the staff of the Assistant Chief of Staff, Intelligence. Upon leaving the military, he was a defense contractor managing the development of computer-based training programs for the USAF and US Navy.
Scott Howington, Global Head of Development and Marketing
Scott is responsible for worldwide marketing, member development, and channel vendor programs. He works with prospective and member companies to increase their SAFE-BioPharma usage. Prior to joining SAFE-BioPharma, Scott developed a broad portfolio of successful strategic sales plans and business development for enterprise software solutions in the pharmaceutical, biopharmaceutical, and medical device industries. He successfully built key strategic accounts, leveraging large global initiatives around CTMS, CDM, RDC, EDC, cloud computing, business intelligence, business process management, ePRO, and global compliance
Tanya supports Business, Governance, Compliance and Regulatory Affairs for SAFE-BioPharma. She also supports the Business and Implementation and Global Regulatory Working Groups and the SAFE-BioPharma EU Advisory Council and works closely with other organizations with which SAFE-BioPharma collaborates.
She most recently was Manager, US Preclinical Development Protocol & Report Operations in Johnson & Johnson’s Pharmaceutical Research and Development organization. In this role Tanya managed people, processes, and projects relating to early and late development submissions for Preclinical Research. In addition, she was the Functional Area Lead for US Preclinical and Global Discovery Teams for both the Documentum and Core Dossier systems. She holds a BA in business and communications from Jones International University.
Jon Weisberg, Director, Communications and Public Relations
Jon is responsible for the association’s public relations and communications outreach. He also manages trademark activities for the SAFE-BioPharma brand.
He was a senior public relations executive with Bristol-Myers Squibb Company and an executive in several public relations agencies. He also serves as president of Weisberg Communications Company, a public relations and communications consulting firm and is an adjunct professor in the graduate communications program of Westminster College in Salt Lake City.
Gary C. Wilson, Technical Program Manager
Gary is responsible for helping prospective and existing association members plan and implement digital identity and signature projects using the SAFE-BioPharma digital standard. He also is involved in managing a variety of SAFE-BioPharma Association services and procedures.
His extensive IT project management experience in the biopharmaceutical industry includes several information management positions in the Ortho-McNeil unit of Johnson & Johnson specializing in public key infrastructure (PKI) security deployment, SOX compliance, quality assurance and validation. Most recently, he was project manager and validation consultant for EMC Consulting Services and for Omicron Consulting.
Gary holds an MBA in finance from Pace University and a BS in business and economics from Lehigh University.
